Digital Health and Artificial Intelligence: Drivers in Transforming the Life Sciences Industry
Join us in Zürich for our next Women’s Life Sciences Network event, which will feature a panel discussion with leading life sciences industry women about the use of artificial intelligence and digital health.
Moderated panel discussion:
- Data augmenting in healthcare
- Challenges and opportunities in digital health
- Artificial intelligence in drug development and beyond
SPEAKERS
Fleur Herrenschmidt
Head Legal Region Europe Pharma
Novartis
Lisa Kinsella
Vice President and General Counsel
Moderna
Afua van Haasteren
Manager, Health Policy and External Affairs
Roche Diagnostics
5:00 – 8:00 p.m. CET
The panel discussion will be followed by a networking reception and walking dinner.
For more information, please contact Cristina Menendez Ruiz at +32 2 504 6453 or at cmenendezruiz@sidley.com.
Click here to join the Women’s Life Sciences Network LinkedIn Group.
Josefine Sommer
Senior Managing Associate, Sidley Austin LLP
WLSN Co-Founder
josefine.sommer@sidley.com
Tatjana Sachse
Counsel, Sidley Austin LLP
WLSN Lead
tsachse@sidley.com
Anna Pavlou
Head of Legal, Global R&D and Regulatory at Galderma
WLSN Co-Founder
Anna.Pavlou@galderma.com
In light of the COVID-19 pandemic, Sidley is taking precautions to safeguard the well-being of our clients, colleagues, and guests. We encourage you to practice social distancing and follow local guidelines. If you are experiencing cold- or flu-like symptoms or if you have been in contact with anyone who has been exposed to or infected with COVID-19 within the past 14 days, please refrain from attending this event. We appreciate your cooperation and concern for the health and safety of our guests.